Bristol Myers Squibb (BMY) closed down more than -3% after forecasting 2025 adjusted EPS of $6.55-$5.85, below the consensus of $6.92.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback